Global Innovative Platforms (GIPL) Cash & Current Investments (2021 - 2026)
Global Innovative Platforms' (GIPL) quarterly Cash & Current Investments came in at $244235.0 in Q2 2026, up 23.27% year-over-year from $198137.0 in Q2 2025, and down 25.37% quarter-over-quarter from $327270.0 in Q1 2026.
Powered by 
Analysis
Global Innovative Platforms (GIPL) Cash & Current Investments (2021 - 2026) Analysis & Trends
Global Innovative Platforms has disclosed Cash & Current Investments across 6 years of filings, most recently posting $244235.0 for Q2 2026.
- In Q2 2026, Cash & Current Investments rose 23.27% year-over-year to $244235.0; the TTM figure through Jun 2026 stood at $244235.0 (up 23.27% YoY), while the FY2025 annual figure was $17828.0, up 118753.33% from the prior year.
- Cash & Current Investments came in at $244235.0 for Q2 2026 at Global Innovative Platforms, down from $327270.0 in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $327270.0 in Q1 2026 to a low of $15.0 in Q3 2024.
- Average Cash & Current Investments over 5 years is $70539.2, with a median of $13987.0 recorded in 2024.
- Year-over-year, Cash & Current Investments plunged 99.13% in 2023 and surged 118753.33% in 2025.
- Over 5 years, Cash & Current Investments stood at $64403.0 in 2022, then plunged by 97.38% to $1685.0 in 2023, then surged by 8710.62% to $148459.0 in 2024, then slumped by 66.99% to $49004.0 in 2025, then jumped by 398.4% to $244235.0 in 2026.
- Per Business Quant data, the three most recent Cash & Current Investments figures were $244235.0 in Q2 2026, $327270.0 in Q1 2026, and $49004.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 196.93 Mn |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | 1.68 Bn |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | 530.00 Mn |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | 81.99 Mn |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | 8.86 Mn |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | 7.10 Mn |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | 244,235.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 244,235.00 |
| Mar 31, 2026 | 327,270.00 |
| Dec 31, 2025 | 49,004.00 |
| Sep 30, 2025 | 17,828.00 |
| Jun 30, 2025 | 198,137.00 |
| Mar 31, 2025 | 155,909.00 |
| Dec 31, 2024 | 148,459.00 |
| Sep 30, 2024 | 15.00 |
| Jun 30, 2024 | 10,146.00 |
| Mar 31, 2024 | 596.00 |
| Dec 31, 2023 | 1,685.00 |
| Sep 30, 2023 | 415.00 |
| Jun 30, 2023 | 361.00 |
| Mar 31, 2023 | 2,961.00 |
| Dec 31, 2022 | 64,403.00 |
| Sep 30, 2022 | 47,757.00 |
| Jun 30, 2022 | 262.00 |
| Mar 31, 2022 | 262.00 |
| Dec 31, 2021 | 262.00 |
| Sep 30, 2021 | 262.00 |